The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

April 2012

Volume 52, Issue 4

Pages NP1–NP3, 457–614

  1. Erratum

    1. Top of page
    2. Erratum
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Special Populations
    7. Pharmacovigilance
    8. Drug Interactions
    9. Brief Report
    10. Letter to the Editor
    1. You have free access to this content
      Erratum (pages NP1–NP3)

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011433286

  2. Review

    1. Top of page
    2. Erratum
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Special Populations
    7. Pharmacovigilance
    8. Drug Interactions
    9. Brief Report
    10. Letter to the Editor
    1. SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes Mellitus (pages 457–463)

      Dr Raktim Kumar Ghosh, Dr Samhati Mondal Ghosh, Dr Shalini Chawla and Dr Sarfaraz Abdeli Jasdanwala

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011400604

  3. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Erratum
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Special Populations
    7. Pharmacovigilance
    8. Drug Interactions
    9. Brief Report
    10. Letter to the Editor
    1. Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single-Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel μ-Opioid Receptor Inverse Agonist (pages 464–474)

      Dr Pradeep J. Nathan, Dr Barry V. O'Neill, Dr Mark A. Bush, Dr Annelize Koch, Dr Wenli X. Tao, Ms Kay Maltby, Dr Antonella Napolitano, Ms Allison C. Brooke, Mr Andrew L. Skeggs, Mr Craig S. Herman, Dr Andrew L. Larkin, Dr Diane M. Ignar, Dr Duncan B. Richards, Dr Pauline M. Williams and Dr Edward T. Bullmore

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011399577

    2. Population Pharmacokinetics and Exposure-Response of Albinterferon Alfa-2b (pages 475–486)

      Dr Matthew M. Riggs, Dr Timothy T. Bergsma, Dr James A. Rogers, Dr Marc R. Gastonguay, Dr G. Mani Subramanian, Dr Cecil Chen, Dr Matt Devalaraja, Mr Alfred E. Corey, Dr Haiying Sun, Dr Jing Yu and Dr Daniel S. Stein

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011399576

    3. Pharmacodynamic Modeling of the Effects of Lanreotide Autogel on Growth Hormone and Insulin-Like Growth Factor 1 (pages 487–498)

      Dr María J. Garrido, Dr Josep-María Cendrós, Dr Joaquim Ramis, Dr Concepción Peraire, Dr Rosendo Obach and Dr Iñaki F. Trocóniz

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011399761

    4. Crossover Dose Escalation Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of R1663, an Oral Factor Xa Inhibitor, in Healthy Male Volunteers (pages 499–510)

      Dr Christophe Schmitt, Dr Anne Pannier, Dr Christine McIntyre, Dr Hagen Zandt, Dr Cornelia Ciorciaro, Ms Katie Winters and Mr Tom Pepper

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011401621

    5. The Pharmacogenetics of NAT2 Enzyme Maturation in Perinatally HIV Exposed Infants Receiving Isoniazid (pages 511–519)

      Dr Rui Zhu, Dr Jennifer J. Kiser, Dr Heiner I. Seifart, Mr Cedric J. Werely, Dr Charles D. Mitchell, Dr David Z. D'Argenio and Dr Courtney V. Fletcher

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011402826

    6. Thorough QT/QTc Study of Ritonavir-Boosted Saquinavir Following Multiple-Dose Administration of Therapeutic and Supratherapeutic Doses in Healthy Participants (pages 520–529)

      Dr Xiaoping Zhang, Dr Paul Jordan, Ms Laura Cristea, Dr Miklos Salgo, Ms Rana Farha, Mr Stanley Kolis and Dr Lois S. Lee

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011400071

  4. Pharmacokinetics

    1. Top of page
    2. Erratum
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Special Populations
    7. Pharmacovigilance
    8. Drug Interactions
    9. Brief Report
    10. Letter to the Editor
    1. In Vitro and In Vivo Assessment of Renal Drug Transporters in the Disposition of Mesna and Dimesna (pages 530–542)

      Dr M. J. Cutler, Dr B. L. Urquhart, Mr T. J. Velenosi, Dr H. E. Meyer zu Schwabedissen, Dr G. K. Dresser, Ms B. F. Leake, Dr R. G. Tirona, Dr R. B. Kim and Dr D. J. Freeman

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011400414

  5. Special Populations

    1. Top of page
    2. Erratum
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Special Populations
    7. Pharmacovigilance
    8. Drug Interactions
    9. Brief Report
    10. Letter to the Editor
    1. Pharmacokinetics of Oral Tonapofylline and Its Acyl-Glucuronide Metabolite in Patients With Mild and Moderate Hepatic Impairment (pages 543–551)

      Dr. Zhaoyang Li, Dr Liang-Shang Gan, Dr Thomas Marbury, Dr Kenneth C. Lasseter, Ms Amy Natarajan, Mr Scott Stecher, Dr Dong Wei, Dr Liyu Yang, Dr Daniel Freedman and Dr Aaron Deykin

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011400413

    2. Effect of Hepatic Impairment on the Pharmacokinetics of Pasireotide (SOM230): Results From a Multicenter Phase I Study (pages 552–558)

      Dr Yves Horsmans, Dr Ke Hu, Mr Matthieu Ruffin, Dr Ying Wang, Dr Dongweon Song, Emmanuel Bouillaud, Dr Yanfeng Wang, Dr Dago Mazur, Dr Frans-Peter Botha and Dr Douglas M. Heuman

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011400072

  6. Pharmacovigilance

    1. Top of page
    2. Erratum
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Special Populations
    7. Pharmacovigilance
    8. Drug Interactions
    9. Brief Report
    10. Letter to the Editor
    1. Cost of Adverse Drug Reactions in a South Indian Tertiary Care Teaching Hospital (pages 559–565)

      Mr. Thiyagu Rajakannan, Mr. Surulivelrajan Mallayasamy, Mr. Vasudeva Guddattu, Dr Asha Kamath, Mr. Rajesh Vilakkthala, Dr Padma G. M. Rao and Dr Laxminarayana K. Bairy

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011398867

    2. Direct Medical Costs of Liquid Intravenous Immunoglobulins in Children, Adolescents, and Adults in Spain (pages 566–575)

      Dr Josep Darbà, Mrs Gabriela Restovic, Mrs Lisette Kaskens and Dr Tuy de Agustín

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011399575

  7. Drug Interactions

    1. Top of page
    2. Erratum
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Special Populations
    7. Pharmacovigilance
    8. Drug Interactions
    9. Brief Report
    10. Letter to the Editor
    1. Aprepitant Pharmacokinetics and Assessing the Impact of Aprepitant on Cyclophosphamide Metabolism in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation (pages 586–594)

      Dr Joseph S. Bubalo, Dr Ganesh Cherala, Dr Jeannine S. McCune, Dr Myrna Y. Munar, Dr Sunny Tse and Dr Richard Maziarz

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011398243

  8. Brief Report

    1. Top of page
    2. Erratum
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Special Populations
    7. Pharmacovigilance
    8. Drug Interactions
    9. Brief Report
    10. Letter to the Editor
    1. Pharmacokinetics of Intranasal Crushed OxyContin and Intravenous Oxycodone in Nondependent Prescription Opioid Abusers (pages 600–606)

      Dr M. R. Lofwall, Dr D. E. Moody, Dr W. B. Fang, Mr. P. A. Nuzzo and Dr S. L. Walsh

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011401620

    2. Subconjunctival Injection of Triamcinolone Acetonide in the Management of Corneal Graft Rejection and New Vessels (pages 607–612)

      Ioannis Athanasiadis, Deric de Wit, Amit K. Patel and Anant Sharma

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270011400073

  9. Letter to the Editor

    1. Top of page
    2. Erratum
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacokinetics
    6. Special Populations
    7. Pharmacovigilance
    8. Drug Interactions
    9. Brief Report
    10. Letter to the Editor

SEARCH

SEARCH BY CITATION